Final safety and efficacy update of SUPLEXA-101, a first-in-human, single agent study of SUPLEXA therapeutic cells in metastatic solid tumors

SUPLEXA cell therapy - Alloplex Biotherap

https://dx.doi.org/10.1136/jitc-2024-SITC2024.0608

Rohit Joshi1; Jeffrey C Goh2; Ganessan Kitchenadasse3; Victoria Atkinson4; Sarwan Bishnoi1; Warren Joubert5; Vineet Kwatra1; Meena Okera1; George Nisyrios6; James A Lederer7; Frank Borriello8; Sharron Gargosky8

Oct 4, 2024